Rituximab Effects Evident at Low Dose, Persist After Treatment Stops

Rituximab Effects Evident at Low Dose, Persist After Treatment Stops

284722

Rituximab Effects Evident at Low Dose, Persist After Treatment Stops

Rituximab shows long-term benefits, even among people with relapsing-remitting multiple sclerosis (RRMS) and clinically isolated syndrome (CIS) who stopped its use or reduced their dose, a study reported. Researchers found little evidence of disease reactivation among patients who discontinued the medication, and an adequate inflammatory disease suppression among those whose annual doses were under 1,000 mg. The study, “Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis,” was published in the Journal of Neurology. Rituximab,…

You must be logged in to read/download the full post.